Drawing the battle lines: what does autumn hold for life sciences?

Herbie Headshots.png

In the second of our series of blogs looking ahead to the General Election, Policy and Public Affairs Executive, Herbie Lambden provides an update on how the two major parties’ approaches to life sciences are evolving.

For both parliamentarians and policy wonks, Summer Recess provides an opportunity to take stock. While the silly season occupies newspaper front pages and politicians plan their next moves, the good work of the UK’s life sciences sector continues.

Since my previous blog on ‘the long and winding road’ behind Labour’s policymaking, three by-elections and a landmark policy forum have reshaped the political environment. Keep reading for an assessment of where these developments leave our sector as we head into a busy autumn.

Policy wrangling in Nottingham

Labour’s manifesto development rolls on, with the National Policy Forum (NPF) assembling in Nottingham at the end of July to discuss amendments to the party’s draft policy programme.


Keir Starmer speaks at the NPF meeting in July, flanked by Deputy Leader Angela Rayner and Shadow Treasury Minister Pat McFadden. BBCPA Media..jpg
Keir Starmer speaks at the NPF meeting in July, flanked by Deputy Leader Angela Rayner and Shadow Treasury Minister Pat McFadden. BBC/PA Media.

Obscured by headline flashpoints like the two-child benefit cap, life sciences appeared in Labour’s framework for the first time. According to LabourList, an amendment pledged the creation of a ‘comprehensive innovation and adoption strategy’ to capitalise on the strength of UK life sciences and NHS data.

The framework now also includes an ambition to make the NHS app a ‘one-stop shop for health information’, making the NHS ‘the preferred provider of commissioned healthcare services’, and a stronger response to the US Inflation Reduction Act (IRA) to increase investment in green manufacturing.

For now, Labour look set to include NHS innovation and life sciences in their vision for government. However, the NPF is just one part of the iterative process of building consensus around Labour’s next manifesto.

The final decision rests with Starmer, who is constrained by the party’s pre-election fiscal discipline. We need to continue to raise awareness of the value of UK life sciences to avoid these ambitions being sacrificed at the altar of electoral success in favour of more headline-grabbing policies.

Fallout over Uxbridge

With Labour, the Lib Dems, and the Tories winning one apiece, July’s by-elections provided a mixed picture. Swingometer-breaking results in Somerton and Selby lived up to projections of a Tory wipeout at the next general election, but their defence of Uxbridge and South Ruislip served as a reminder that there are no foregone conclusions in politics.

Steve Tuckwell speaks after winning the Uxbridge and South Ruislip by-election. PoliticoCarl Court..jpg
Steve Tuckwell speaks after winning the Uxbridge and South Ruislip by-election. Politico/Carl Court.

The fallout from Uxbridge has focused on the electoral attractiveness of Net Zero. The ULEZ discourse has spilled over into disagreement between Starmer and Sadiq Khan, fanned by bluster in the press about ‘the beginning of the end of Britain’s Net Zero consensus’.

With Sunak’s commitment to hitting the Net Zero target by 2050 still intact, the reality is less stark, but it does raise questions for life sciences. In a period of high inflation and squeezed household budgets, are the climate change solutions offered by our sector still attractive to politicians and the electorate?

Polling has shown that public support for green policies remains high, falling among those struggling financially where such measures cut across the cost of living crisis. The Tories also remain far greener than their right-of-centre counterparts in France and Germany. The realignment on Net Zero is therefore more one of presentation than policy, fabricating a dividing line between the Tories and Labour.

This serves to show the power of messaging when it comes to sustainability. Life science innovations will need to be marketed as both transformative and cost-saving if they are to be taken up and included in manifestoes.

With a further by-election in Glasgow now set for autumn, we will have another opportunity to assess Labour’s electoral chances. Any significant progress against the SNP will be taken as a bellwether for a Labour victory in 2024.

Looking ahead to Manchester and Liverpool

October’s party conference season is always febrile, but this year’s should be especially so. Policies debated and voted on in Manchester and Liverpool could form the backbone of manifestoes going into an election year.

Politicians from both parties will be eager to iron out policy disagreements before Parliament returns and the King’s Speech and Chancellor’s Autumn Statement set the legislative agenda for the run-up to the election.

The next twelve months present a difficult landing zone for life sciences policy. The Tories have a narrowing window for implementing policy, favouring short-term wins over broader strategy. Meanwhile, Starmer and Shadow Chancellor Rachel Reeves continue to resist calls for new spending commitments, precluding any imminent announcement of an industrial strategy for our sector.

The BIA will be on the ground at both conferences, making the case for sustainable innovation in biotech to form a major strand of parties’ visions for the UK.


More news and updates 


Dispatches from the party conferences – Liberal Democrats

In this first instalment of dispatches by the BIA team attending the conferences, Dr. Martin Turner, BIA's Head of Policy and Public Affairs, reports on what he’s heard from the Liberal Democrats.

Women In Biotech Mentoring Programme: Mentee experience – Alex Gajdosova

In this interview, Alex Gajdosova, an Investment Analyst at 4BIO Capital reflects on her inspiring career journey and her decision to participate in the BIA’s Women In Biotech Mentoring Programme as a mentee.

CEO Update - 25 September 2023

The government is introducing legislation to reverse the reinstatement of the 1.5% stamp tax charge on issues and certain transfer of shares to depositary receipts issuers and clearance services – so as, broadly, to preserve the position as before the Retained EU Law (Revocation and Reform) Act was passed.

Women In Biotech Mentoring Programme: mentee experience - Hilary Birrell

In this interview, we delve into the remarkable career journey of Hilary Birrell, a seasoned biochemist with 35 years of experience in clinical trial operations. She shares her motivation for becoming a mentee in the Women In Biotech Mentoring Programme and the invaluable insights gained from her mentor.

CEO Update - 18 September 2023

It was an honour to represent our sector at the first-ever meeting of the UK Biosecurity Leadership Council, chaired by Science Minister George Freeman MP. Looking around the table, it was clear to see that the UK’s strategic advantage in the responsible use of engineering biology is that we have a diverse and world-leading set of capabilities from pioneering science to regulation and thought leadership – and that we are small enough, and networked enough as a nation to get together in a room to set agendas and work plans at pace and scale that can be globally impactful.

Powering regional growth: the Cambridge cluster

Our burgeoning life sciences sector contributes £94 billion to the UK’s economy each year and employs over 280,000 people. But did you know that Cambridge as a region is home to one of the world’s most successful life sciences and biotechnology hubs?

Alzheimer’s disease diagnosis and treatment: Never too early, never too late

September is World Alzheimer’s Month but in the history of diagnosis and treatment of Alzheimer’s disease (AD), 2023 will go down as a landmark year of progress.

CEO Update - 11 September 2023

Last week, the UK scientists celebrated the rejoining Horizon Europe research programme. For research and the flow of talented scientists, it is undoubtedly a good thing that has taken too long to agree. The UK government press release was clear that “Horizon will give UK COMPANIES and research institutions unrivalled opportunities to lead global work to develop new technologies and research projects, in areas from HEALTH to AI”.


More within